These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37566283)

  • 1. MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation.
    Schirone L; Vecchio D; Valenti V; Forte M; Relucenti M; Angelini A; Zaglia T; Schiavon S; D'Ambrosio L; Sarto G; Stanzione R; Mangione E; Miglietta S; Di Bona A; Fedrigo M; Ghigo A; Versaci F; Petrozza V; Marchitti S; Rubattu S; Volpe M; Sadoshima J; Frati L; Frati G; Sciarretta S
    Cell Mol Life Sci; 2023 Aug; 80(9):245. PubMed ID: 37566283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo pathway activation mediates chemotherapy-induced anti-cancer effect and cardiomyopathy through causing mitochondrial damage and dysfunction.
    She G; Du JC; Wu W; Pu TT; Zhang Y; Bai RY; Zhang Y; Pang ZD; Wang HF; Ren YJ; Sadoshima J; Deng XL; Du XJ
    Theranostics; 2023; 13(2):560-577. PubMed ID: 36632235
    [No Abstract]   [Full Text] [Related]  

  • 3. Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes.
    Cheung KG; Cole LK; Xiang B; Chen K; Ma X; Myal Y; Hatch GM; Tong Q; Dolinsky VW
    J Biol Chem; 2015 Apr; 290(17):10981-93. PubMed ID: 25759382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mst1 inhibits Sirt3 expression and contributes to diabetic cardiomyopathy through inhibiting Parkin-dependent mitophagy.
    Wang S; Zhao Z; Fan Y; Zhang M; Feng X; Lin J; Hu J; Cheng Z; Sun C; Liu T; Xiong Z; Yang Z; Wang H; Sun D
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1905-1914. PubMed ID: 29674007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
    Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
    J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis.
    Zhang P; Lu H; Wu Y; Lu D; Li C; Yang X; Chen Z; Qian J; Ge J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3.
    Zhang W; Fan Z; Wang F; Yin L; Wu J; Li D; Song S; Wang X; Tang Y; Huang C
    Oxid Med Cell Longev; 2023; 2023():9966355. PubMed ID: 36691640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rab10 protects against DOX-induced cardiotoxicity by alleviating the oxidative stress and apoptosis of cardiomyocytes.
    Zhang C; Dan Q; Lai S; Zhang Y; Gao E; Luo H; Yang L; Gao X; Lu C
    Toxicol Lett; 2023 Jan; 373():84-93. PubMed ID: 36309171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
    Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
    PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
    Zhu W; Reuter S; Field LJ
    Cardiovasc Res; 2019 Apr; 115(5):960-965. PubMed ID: 30423020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matricellular protein CCN1 mediates doxorubicin-induced cardiomyopathy in mice.
    Hsu PL; Mo FE
    Oncotarget; 2016 Jun; 7(24):36698-36710. PubMed ID: 27167338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
    Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
    Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Sirtuin-3 (SIRT3) Prevents Doxorubicin-Induced Dilated Cardiomyopathy by Modulating Protein Acetylation and Oxidative Stress.
    Tomczyk MM; Cheung KG; Xiang B; Tamanna N; Fonseca Teixeira AL; Agarwal P; Kereliuk SM; Spicer V; Lin L; Treberg J; Tong Q; Dolinsky VW
    Circ Heart Fail; 2022 May; 15(5):e008547. PubMed ID: 35418250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.
    McLaughlin D; Zhao Y; O'Neill KM; Edgar KS; Dunne PD; Kearney AM; Grieve DJ; McDermott BJ
    Br J Pharmacol; 2017 Nov; 174(21):3677-3695. PubMed ID: 28261787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice.
    Pillai VB; Bindu S; Sharp W; Fang YH; Kim G; Gupta M; Samant S; Gupta MP
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H962-72. PubMed ID: 26873966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and glucocorticoid inducible kinase 1 modulates mitochondrial dysfunction and oxidative stress in doxorubicin-induced cardiomyocytes by regulating Hippo pathway via Neural precursor cell-expressed developmentally down-regulated 4 type 2.
    Zou Z; Zhao T; Zeng Z; An Y
    Hum Exp Toxicol; 2023; 42():9603271231158039. PubMed ID: 36781297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.
    Zhuang X; Sun X; Zhou H; Zhang S; Zhong X; Xu X; Guo Y; Xiong Z; Liu M; Lin Y; Zhang M; Liao X
    Mech Ageing Dev; 2021 Apr; 195():111442. PubMed ID: 33539906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Protect Cardiomyocytes from Doxorubicin-Induced Cardiomyopathy by Upregulating Survivin Expression via the miR-199a-3p-Akt-Sp1/p53 Signaling Pathway.
    Lee JY; Chung J; Byun Y; Kim KH; An SH; Kwon K
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP-2 mediates cardiomyocyte aging and damage induced by doxorubicin through SIRT1 Inhibition.
    Huang C; Zhang X; Wang S; Shen A; Xu T; Hou Y; Gao S; Xie Y; Zeng Y; Chen J; Lin R; Zhang Y; Wan C; Cai Y
    Apoptosis; 2024 Jun; 29(5-6):816-834. PubMed ID: 38281279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.